| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 6 Feb 2026 | 2 Feb 2026 |
| Alchemist Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company will be held on Friday 06 February 2026 inter-alia to consider and approve the Unaudited Financial Results of the Company both on Standalone and Consolidated basis for the quarter and nine months ended December 31 2025. In continuation to our letter dated December 26 2025 regarding the closure of Trading Window from January 1 2026 till 48 hours after public announcement of the Unaudited Financial Results for the quarter and nine months ended December 31 2025 we wish to inform you that the Trading Window will remain closed till February 08 2026. In continuation to our earlier communication dated 02T February, 2026 and pursuant to Regulation 30, 33 and other applicable regulations read with Schedule Il of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations, 2015) as amended from time to time, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. on Friday, 06th February 2026 at the registered office of the Company, commenced at 03:00 PM and concluded at 04.00 PM, transacted, inter alia, the following businesses: 1. Approved the Unaudited Standalone and Unaudited Consolidated Financial Results for the quarter and nine month ended 31% December, 2025, as per the provisions of Regulation 33 of SEBI Listing Regulations, 2015, together with the Limited Review Report(s) thereon issued by M/s. Krishan Rakesh & Co, Chartered Accountants, Statutory Auditors. We are hrereby submting the financial result for quater ended 31st December, 2025 under regulation 33 of SEBI (LODR) Regulation 2015. (As Per BSE Announcement Dated on:06.02.2026) | ||
| Board Meeting | 14 Nov 2025 | 7 Nov 2025 |
| Quarterly Results; Alchemist Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve Dear Sir/Madam, Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company will be held on Friday, November 14, 2025 inter-alia, to consider and approve the Unaudited Financial Results of the Company, both on Standalone and Consolidated basis, for the 2nd Quarter and half year ended September 30, 2025. In continuation to our letter dated September 25, 2025, regarding the closure of Trading Window from October 1, 2025 till 48 hours after public announcement of the Unaudited Financial Results for the 2nd Quarter and half year ended September 30, 2025, we wish to inform you that the Trading Window will remain closed till November 16, 2025. You are requested to take the same on record. Outcome of board meeting dated November 14, 2025 (As Per BSE Announcement Dated on 14.11.2025) Additional Details regarding Board Meeting held on November 14th, 2025. (As Per BSE Announcement Dated on 17.11.2025) | ||
| Board Meeting | 5 Sep 2025 | 5 Sep 2025 |
| To BSE Limited Corporate Relations Department 1st Floor, New Trading Ring P.J. Towers Dalat Street Mumbai-400001 Script Code: 531409 Subject: Outcome of Board Meeting Dear Sir/Maam With reference to the captioned subject above, & pursuant to regulation 30 of the SEBI Listing Regulations, please note that the Board of Directors of the Company in their meeting held on 5th September 2025 have approved the following: Recommendation for Appointment of M/S Krishan Rakesh & Co as Statutory Auditors of the Company Yours Faithfully Arjit Sachdeva Managing Director DIN:07589173 | ||
| Board Meeting | 13 Aug 2025 | 7 Aug 2025 |
| Quarterly Results-Alchemist Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve Dear Sir/Madam, Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company will be held on Wednesday, August 13, 2025 inter-alia, to consider and approve the Unaudited Financial Results of the Company, both on Standalone and Consolidated basis, for the Quarter ended June 30, 2025. In continuation to our letter dated June 27, 2025, regarding the closure of Trading Window from July 1, 2025 till 48 hours after public announcement of the Unaudited Financial Results for the Quarter ended June 30, 2025, we wish to inform you that the Trading Window will remain closed till August 15, 2025. You are requested to take the same on record. In continuation of our ealier communication and pursuant to Regulation 30, 33 and other applicable regulations read with Schedule III of Listing Regulations as amended from time to time, we wish to inform you that the Board of the Company at its meeting held today transacted inter alia the following business: 1. Approved the unaudited standalone and unaudited consolidated financial results for the quarter ended June 30, 2025 as per the provisions of Regulation 33 of Listing Regulations, together with the Limited Review Report(s) thereon issued by M/s. Krishan Rakesh & Co., Chartered Accountants, Statutory Auditors 2. Appointment of Mr. Akshay Chaturvedi (DIN: 0326661) as an Additional Director (Non Executive, Non-Independent) and Chairman of the Company 3. Resignation of Mr. Rahul Sharma (DIN:08023343) as an Additonal Director (Non Executive, Non-Independent) Director and Chairman of the Company 4. Reconstitution of Committee of Board of Directors of the Company (As Per BSE Announcement Dated on: 13.08.2025) | ||
| Board Meeting | 6 Jun 2025 | 6 Jun 2025 |
| Intimation for Change in Management & Control under Regulation 30 of Securities and Exchange Board of India (LODR) Regulation ,2015 | ||
| Board Meeting | 30 May 2025 | 23 May 2025 |
| Alchemist Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve and take record of the standalone and consolidated Audited Financial Results for the quarter and year ended on March 312025 This is with reference to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In this regard, we wish to inform you that the Board of Directors in its meeting held today i.e. on Friday, 30th May, 2025 has considered and approved the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2025 together with Auditors Reports of the Statutory Auditors. The copies of the same are enclosed herewith. Financial Results for the year ended March 31,2025 (As per BSE Announcement Dated on 30/05/2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
